Retinal photoreceptor cell protection

"Retinal photoreceptor cell protection" refers broadly to strategies aimed at preventing the degeneration and death of rod and cone cells in the retina—cells essential for vision. Photoreceptor loss underlies many blinding diseases including retinitis pigmentosa and age-related macular degeneration. Protective mechanisms involve reducing oxidative stress, modulating intracellular calcium levels, inhibiting apoptotic pathways (such as those involving c-fos/AP‑1), enhancing neurotrophic support through factors like PEDF acting on its receptor PEDF-R, and activating intrinsic survival pathways such as CREB1/ATF1-mediated transcriptional programs. This term does not denote a single molecular target but encompasses multiple possible targets within these protective processes.

Mechanisms by which drugs may protect retinal photoreceptors include: Antioxidant activity/free radical scavenging; Inhibition of apoptotic pathways (e.g., caspase inhibition); Modulation of calcium homeostasis via plasma membrane Ca²⁺ ATPase pumps; Activation of neuroprotective signaling pathways such as CREB1/ATF1 transcription factors.